Oculis
Clinical trials sponsored by Oculis, explained in plain language.
-
Eye drop trial offers hope for diabetic vision loss
Disease control OngoingThis study is testing whether OCS-01 eye drops can safely reduce swelling in the retina and improve vision for people with diabetic macular edema. The trial involves 552 participants and compares the eye drops to a placebo over 52 weeks. The goal is to find a non-invasive treatme…
Phase: PHASE2, PHASE3 • Sponsor: Oculis • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Eye drop trial offers new hope for diabetic vision loss
Disease control OngoingThis study is testing whether OCS 01 eye drops can safely improve vision in people with diabetic macular edema, a common cause of vision loss in diabetes. About 401 participants will use either the active eye drops or a placebo (vehicle) solution twice daily for a year. Researche…
Phase: PHASE3 • Sponsor: Oculis • Aim: Disease control
Last updated Mar 09, 2026 14:22 UTC